101 completed, 88 unknown, 14 terminated, 11 withdrawn. 48 Phase 2, 45 Not applicable, 37 Phase 3, 16 Phase 1, 12 Phase 4.
Follow COVID-19 Pneumonia: new trials by email Literature Review of COVID-19 Pneumonia trials Research Report on COVID-19 Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19 additional EIT Measurement - COVID-19 Pneumonia, Post-acute COVID-19 Syndrome | Not yet recruiting | Jan-Christoph Lewejohann | 50 | 2025-10-01 | 2025-09-25 | |
| Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19. Blood samples and Oropharyngeal swab, Six-minute walk test, Spirometry, ECG, Heart ultrasound and cardiopulmonary exercise stress testing, Completion of questionnaires of symptoms - Pneumonia, Community-Acquired, COVID-19 Pneumonia | Recruiting | Hellenic Institute for the Study of Sepsis | 650 | 2024-11-08 | 2026-07-06 | |
| Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias Allogeneic Mesenchymal Stromal Cells - COVID-19 Pneumonia, Viral Pneumonia | Phase 1 | Withdrawn | Medical University of South Carolina | 2024-10-01 | 2024-10-30 | |
| AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes Medical software (AI-based system) - Pneumonia, Viral, COVID-19 Pneumonia | Unknown | Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department | 563 | 2024-06-03 | 2024-07-22 | |
| Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19 Bailing capsule - Pulmonary Fibrosis, COVID-19 Pneumonia | Not applicable | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 242 | 2024-04-16 | 2024-04-17 |
| NAC for Attenuation of COVID-19 Symptomatology N-acetylcysteine, Placebo - Covid19, COVID-19 Pneumonia | Phase 2 | Unknown | Cambridge Health Alliance | 200 | 2024-03-31 | 2023-08-07 |
| Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine A&M Breathalyzer PROTECT Kiosk - COVID-19, SARS CoV 2 Virus | Recruiting | The Geneva Foundation | 100 | 2023-12-27 | 2025-12-10 | |
| CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study Arterial blood gases, Respiratory rate (RR), Pulseoximeter - Pneumonia, Bacterial, Respiratory Failure | Not applicable | Completed | I.M. Sechenov First Moscow State Medical University | 30 | 2023-09-19 | 2024-06-18 |
| Characteristics of Blood Glucose Variability in Patients With Type 2 Diabetes Mellitus and COVID-19 Glucose variability - COVID-19 Pneumonia, Type2diabetes | Unknown | Qilu Hospital of Shandong University | 200 | 2023-08-01 | 2023-12-05 | |
| SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42) imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope - COVID-19, SARS-CoV-2 Virus | Completed | The Geneva Foundation | 300 | 2023-05-15 | 2026-07-15 | |
| Factors Associated With Failure of HFNO in COVID-19 ICU Patients high flow oxygen device - COVID-19 Pneumonia | Unknown | Central Hospital, Nancy, France | 500 | 2023-05-01 | 2023-04-04 | |
| Corona Virus Disease 2019 Cohort Study COVID-19 Pneumonia, COVID-19 Pandemic | Recruiting | Shandong University | 1000 | 2023-04-01 | 2025-04-15 | |
| Efficacy of Lianhua Qingwen in Treating Patients Infected With the Omicron Variant of the COVID-19 The group of patients who received Lianhua Qingwen orally, The group of patients who did not receive Lianhua Qingwen orally - COVID-19 Pneumonia | Unknown | Qianfoshan Hospital | 200 | 2023-03-20 | 2023-05-11 | |
| COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose Pfizer COVID-19 mRNA vaccine, Moderna COVID-19 mRNA vaccine - COVID-19 Pneumonia, COVID-19 | Completed | Methodist Health System | 100 | 2023-03-15 | 2026-03-24 | |
| Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia. Jaktinib, Placebo - COVID-19 Pneumonia | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 60 | 2023-03-01 | 2023-01-17 |
| The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia Non-invasive high-frequency oscillatory ventilation, Non-invasive continuous positive airway pressure ventilation - COVID-19 Pneumonia, Non-invasive Ventilation | Not applicable | Unknown | Guangzhou Institute of Respiratory Disease | 20 | 2023-02-10 | 2023-01-31 |
| Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function GST-HG171 Tablets - COVID-19 Pneumonia | Not applicable | Unknown | Fujian Akeylink Biotechnology Co., Ltd. | 32 | 2023-02-10 | 2023-10-30 |
| A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19. Extracellular Vesicles from Mesenchymal Stem Cells - COVID-19 Pneumonia | Early Phase 1 | Unknown | First Affiliated Hospital of Wenzhou Medical University | 240 | 2023-01-23 | 2023-04-07 |
| Respiratory Muscle Training and Walking Exercise in Women Recovering From COVID-19 Pneumonia Respiratory Muscle Training, Walking Exercise - COVID-19 Pneumonia, Respiratory Symptoms | Not applicable | Completed | Hitit University | 80 | 2023-01-16 | 2026-06-18 |
| Efficacy of Megadose Vitamin C in Severe and Critical Ill COVID-19 Patients. Vitamin C, Placebo - Vitamin C, COVID-19 Pneumonia | Phase 2 / Phase 3 | Unknown | Zhujiang Hospital | 608 | 2023-01-13 | 2023-01-23 |
Showing 20 of 223. Sign in to see all of them.
COVID-19 (107) · Pneumonia (22) · Coronavirus Infections (13) · Respiratory Distress Syndrome (7) · Pneumonia, Viral (6) · Hypoxia (4) · Respiratory Insufficiency (4) · Critical Illness (3) · Cytokine Release Syndrome (3) · Diabetes Mellitus (3) · Fatigue (3) · Influenza, Human (3) · Post-Acute COVID-19 Syndrome (3) · Pulmonary Fibrosis (3) · Respiratory Tract Infections (3)
Respiratory Tract Diseases (128) · Lung Diseases (125) · Infections (121) · Respiratory Tract Infections (115) · Virus Diseases (115) · RNA Virus Infections (112) · Nidovirales Infections (111) · Coronaviridae Infections (110) · Pneumonia, Viral (107) · Coronavirus Infections (98) · Pneumonia (96) · Pathological Conditions, Signs and Symptoms (36) · Pathologic Processes (26) · Respiration Disorders (14) · Disease Attributes (11)
tocilizumab (8) · COVID-19 Vaccines (5) · Prone Position (5) · Standard of Care (5) · Dexamethasone (4) · Methylprednisolone (4) · Sodium Chloride (4) · Ivermectin (3) · remdesivir (3) · Acetaminophen (2) · Acetylcysteine (2) · Ascorbic Acid (2) · Azithromycin (2) · Breathing Exercises (2) · Budesonide (2)
China National Biotec Group Company Limited (6) · Mansoura University (4) · Fujian Akeylink Biotechnology Co., Ltd. (3) · Hamad Medical Corporation (3) · Hoffmann-La Roche (3) · National Vaccine and Serum Institute, China (3) · Afyonkarahisar Health Sciences University (2) · Assiut University (2) · Azienda Sanitaria-Universitaria Integrata di Udine (2) · Bakirkoy Dr. Sadi Konuk Research and Training Hospital (2) · Brno University Hospital (2) · Cairo University (2) · DreamTec Research Limited (2) · Fayoum University (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)
China (29) · Turkey (Türkiye) (25) · United States (25) · Italy (21) · Spain (19) · Egypt (13) · Brazil (12) · Mexico (7) · France (6) · Pakistan (6) · India (5) · Canada (4) · Germany (4) · Russia (4) · United Kingdom (4)
Mara Paneroni, PT (2) · Michael Morris, MD (2) · Rabia Ghafoor, MBBS, FCPS, SCE-Derm(MRCP-UK) (2) · Syeda Mahanum Ali, MBBS, Postgraduate Trainee (2) · Adel El-Badrawy (1) · Adrian Camacho Ortiz, MD (1) · Agnieszka Jankowska, doctor (1) · Ahmed Labib (1) · Aijaz Zeeshan K Chachar, MBBS,FCPS (1) · Ajay Gupta, MD (1) · Alaa Rahhal, Msc (1) · Alexander Hermann, Dr. (1) · Alexander Phan, MD (1) · Alexandre Biasi Cavalcanti, MD, PhD (1)
PMID 34612846, PMID 11990923, PMID 12163791, PMID 12802491, PMID 14564379, PMID 16276177, PMID 17311621, PMID 17381569, PMID 18575846, PMID 19384209, PMID 19691668, PMID 20518086, PMID 20813838, PMID 22263004, PMID 23864363, PMID 23892417, PMID 23944202, PMID 27144617, PMID 27481035, PMID 27626833, PMID 28557528, PMID 29129346, PMID 30431492, PMID 30871304, PMID 31264386, PMID 31274034, PMID 31346914, PMID 31425269, PMID 31437406, PMID 31687831, PMID 31789984, PMID 32167538, PMID 32215647, PMID 32215691, PMID 32228035, PMID 32250385, PMID 32251668, PMID 32291463, PMID 32325004, PMID 32329799, PMID 32338710, PMID 32355007, PMID 32405603, PMID 32412581, PMID 32414420, PMID 32423584, PMID 32445440, PMID 32452888, PMID 32512006, PMID 32569585
1UG3HL141722-01A1 (1), R01HL159055 (1)